GET THE APP

Journal européen d'oncologie clinique

ISSN - 2732-2654

Volume 6, Problème 1 (2024)

Perspective

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspective

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspective

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspective

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspective

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

Perspective

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspective

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspective

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspective

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Perspective

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

Recherche

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Recherche

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Recherche

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Recherche

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

Recherche

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

article de recherche

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

article de recherche

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

article de recherche

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

article de recherche

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

article de recherche

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

Communication courtoise

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Communication courtoise

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Communication courtoise

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Communication courtoise

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

Communication courtoise

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi